238 related articles for article (PubMed ID: 19048196)
1. Approaches for the development of antiviral compounds: the case of hepatitis C virus.
Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ
Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
3. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the discovery of small molecule therapies for HCV.
Myles DC
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306
[TBL] [Abstract][Full Text] [Related]
5. Novel hepatitis C drugs in current trials.
Kronenberger B; Welsch C; Forestier N; Zeuzem S
Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
[TBL] [Abstract][Full Text] [Related]
6. The design of drugs for HIV and HCV.
De Clercq E
Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
[TBL] [Abstract][Full Text] [Related]
7. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
Trepanier JB; Tanner JE; Alfieri C
Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
[TBL] [Abstract][Full Text] [Related]
9. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
Tsantrizos YS
Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
[TBL] [Abstract][Full Text] [Related]
10. Challenges and successes in developing new therapies for hepatitis C.
De Francesco R; Migliaccio G
Nature; 2005 Aug; 436(7053):953-60. PubMed ID: 16107835
[TBL] [Abstract][Full Text] [Related]
11. Future therapies for hepatitis C.
Pawlotsky JM; Gish RG
Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
13. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
14. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
[TBL] [Abstract][Full Text] [Related]
15. Cellular models for the screening and development of anti-hepatitis C virus agents.
Gondeau C; Pichard-Garcia L; Maurel P
Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
[TBL] [Abstract][Full Text] [Related]
16. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
J Hepatol; 2006 Feb; 44(2):411-21. PubMed ID: 16364491
[No Abstract] [Full Text] [Related]
17. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
18. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
Durantel D; Alotte C; Zoulim F
Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
[TBL] [Abstract][Full Text] [Related]
19. A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates.
Cannalire R; Barreca ML; Manfroni G; Cecchetti V
J Med Chem; 2016 Jan; 59(1):16-41. PubMed ID: 26241789
[TBL] [Abstract][Full Text] [Related]
20. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
